Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Metabolites|March 29, 2023
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with ObesityVanessa D'Antongiovanni, Matteo Fornai, Laura Benvenuti, et al.
Toxicology and Applied Pharmacology|February 14, 2004
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compoundsGianfranco Natale, Gloria Lazzeri, Valter Lubrano, et al.
Frontiers in Endocrinology|April 8, 2026
SodiuM glucose cotrANsporter-2 (SGLT-2) inhibitors in the treatment of type II DiAbetes in Tuscany: utiLizatiOn patteRns, and relatEd clinical use evaluation; the MANDALORE study protocolIrma Convertino, Ersilia Lucenteforte, Janette Monzillo, et al.
Drugs & Aging|March 12, 2008
Clinical efficacy of esomeprazole in the prevention and healing of gastrointestinal toxicity associated with NSAIDs in elderly patientsCorrado Blandizzi, Marco Tuccori, Rocchina Colucci, et al.
European Journal of Pharmacology|November 2, 2010
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitisLuca Antonioli, Matteo Fornai, Rocchina Colucci, et al.
Current Drug Targets|January 19, 2012
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disordersLuca Antonioli, Rocchina Colucci, Concettina La Motta, et al.
Medicinal Research Reviews|December 20, 2024
α-Synuclein in Parkinson's Disease: From Bench to BedsideGabriele Bellini, Vanessa D'Antongiovanni, Giovanni Palermo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 14, 2006
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammationMatteo Fornai, Corrado Blandizzi, Luca Antonioli, et al.
European Journal of Pharmacology|January 9, 2007
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colonMatteo Fornai, Rocchina Colucci, Luca Antonioli, et al.
Expert Opinion on Drug Discovery|April 2, 2020
Approaches for designing and discovering purinergic drugs for gastrointestinal diseasesDiego Dal Ben, Luca Antonioli, Catia Lambertucci, et al.
Pageof 13